Literature DB >> 17046183

Mesoporous silica material TUD-1 as a drug delivery system.

T Heikkilä1, J Salonen, J Tuura, M S Hamdy, G Mul, N Kumar, T Salmi, D Yu Murzin, L Laitinen, A M Kaukonen, J Hirvonen, V-P Lehto.   

Abstract

For the first time the feasibility of siliceous mesoporous material TUD-1 (Technische Universiteit Delft) for drug delivery was studied. Model drug, ibuprofen, was adsorbed into TUD-1 mesopores via a soaking procedure. Characterizations with nitrogen adsorption, XRD, TG, HPLC and DSC demonstrated the successful inclusion of ibuprofen into TUD-1 host. The amount of ibuprofen adsorbed into the nanoreservoir of TUD-1 material was higher than reported for other mesoporous silica drug carriers (drug/carrier 49.5 wt.%). Drug release studies in vitro (HBSS buffer pH 5.5) demonstrated a fast and unrestricted liberation of ibuprofen, with 96% released at 210 min of the dissolution assay. The drug dissolution profile of TUD-1 material with the random, foam-like three-dimensional mesopore network and high accessibility to the dissolution medium was found to be much faster (kinetic constant k = 10.7) and more diffusion based (release constant n = 0.64) compared to a mesoporous MCM-41 material with smaller, unidirectional mesopore channels (k = 4.7, n = 0.71). Also, the mesoporous carriers were found to significantly increase the dissolution rate of ibuprofen, when compared to the pure crystalline form of the drug (k = 0.6, n = 0.96). TUD-1 was constituted as a potential drug delivery device with fast release property, with prospective applications in the formulation of poorly soluble drug compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046183     DOI: 10.1016/j.ijpharm.2006.09.019

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  21 in total

1.  The biocompatibility of mesoporous silicates.

Authors:  Sarah P Hudson; Robert F Padera; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2008-10       Impact factor: 12.479

2.  A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib.

Authors:  Yanzhuo Zhang; Hong Wang; Chuanjun Li; Baoxiang Sun; Yu Wang; Siling Wang; Cunqiang Gao
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

3.  Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.

Authors:  Ying Wang; Qinfu Zhao; Yanchen Hu; Lizhang Sun; Ling Bai; Tongying Jiang; Siling Wang
Journal:  Int J Nanomedicine       Date:  2013-10-22

4.  Effective delivery of volatile biocides employing mesoporous silicates for treating biofilms.

Authors:  Andrea C Chan; Marimar Bravo Cadena; Helen E Townley; Mark D Fricker; Ian P Thompson
Journal:  J R Soc Interface       Date:  2017-01       Impact factor: 4.118

Review 5.  Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines.

Authors:  Dixita Ishani Viswanath; Hsuan-Chen Liu; David P Huston; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Biomaterials       Date:  2021-11-30       Impact factor: 12.479

Review 6.  Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review.

Authors:  Josephine Oluwagbemisola Tella; Joseph Adeyemi Adekoya; Kolawole Oluseyi Ajanaku
Journal:  R Soc Open Sci       Date:  2022-06-08       Impact factor: 3.653

7.  TUD-1: synthesis and application of a versatile catalyst, carrier, material…

Authors:  Selvedin Telalović; Anand Ramanathan; Guido Mul; Ulf Hanefeld
Journal:  New J Chem       Date:  2009-08-28       Impact factor: 3.591

Review 8.  Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances.

Authors:  Reema Narayan; Usha Y Nayak; Ashok M Raichur; Sanjay Garg
Journal:  Pharmaceutics       Date:  2018-08-06       Impact factor: 6.321

Review 9.  Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications.

Authors:  Bazla Siddiqui; Asim Ur Rehman; Ihsan-Ul Haq; Amal A Al-Dossary; Abdelhamid Elaissari; Naveed Ahmed
Journal:  Int J Pharm X       Date:  2022-04-19

10.  Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier.

Authors:  Anna Krupa; Jakub Szlęk; Benedykt R Jany; Renata Jachowicz
Journal:  AAPS PharmSciTech       Date:  2014-12-11       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.